Yield10 Bioscience Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
42
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$5M
Yield10 Bioscience General Information
Description
Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed Camelina sativa as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics.
Contact Information
Website
www.yield10bio.comCorporate Office
- 19 Presidential Way
- Woburn, MA 01801
- United States
Corporate Office
- 19 Presidential Way
- Woburn, MA 01801
- United States
Yield10 Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 23. Merger/Acquisition | 01-Jan-2025 | $5M | Completed | Generating Revenue/Not Profitable | ||
| 22. Bankruptcy: Admin/Reorg | 06-Dec-2024 | Completed | Bankruptcy: Admin/Reorg | |||
| 21. 2PO | 09-May-2024 | Cancelled | Generating Revenue | |||
| 20. PIPE | 15-Aug-2023 | Completed | Generating Revenue | |||
| 19. PIPE | 26-Aug-2020 | Completed | Generating Revenue | |||
| 18. PIPE | 19-Nov-2019 | Completed | Generating Revenue | |||
| 17. 2PO | 18-Nov-2019 | Completed | Generating Revenue | |||
| 16. PIPE | 18-Mar-2019 | Completed | Generating Revenue | |||
| 15. PIPE | 03-Jul-2017 | $2.3M | $173M | Completed | Generating Revenue | |
| 14. Secondary Transaction - Open Market | $171M | Completed | Generating Revenue |
Yield10 Bioscience Comparisons
Industry
Financing
Details
Yield10 Bioscience Competitors (5)
One of Yield10 Bioscience’s 5 competitors is Amyris (Biotechnology), a Private Equity-Backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Amyris (Biotechnology) | Private Equity-Backed | Emeryville, CA | ||||
| Edeniq | Venture Capital-Backed | Visalia, CA | ||||
| Ecovia Bio | Venture Capital-Backed | Livonia, MI | ||||
| Cibus (Agriculture) | Formerly VC-backed | San Diego, CA | ||||
| Viaspace | Corporation | Santa Cruz, CA |
Yield10 Bioscience Patents
Yield10 Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024102881-A1 | Transgenic camelina plants genetically modified to be tolerant to glufosinate without exhibiting a decrease in seed yield | Inactive | 11-Nov-2022 | ||
| CA-3188488-A1 | Genetically modified plants that exhibit an increase in seed yield comprising a first biotin attachment domain-containing (badc) gene homozygous for wild-type allele, a second badc gene homozygous for mutant allele, and homologs of the first and second badc gene | Pending | 12-Aug-2020 | ||
| WO-2022036078-A1 | Genetically modified plants that exhibit an increase in seed yield comprising a first biotin attachment domain-containing (badc) gene homozygous for wild-type allele, a second badc gene homozygous for mutant allele, and homologs of the first and second badc genes | Inactive | 12-Aug-2020 | ||
| AU-2021224206-A1 | Genetically engineered plants that express 6-phosphogluconate dehydratase and/or 2-keto-3-deoxy-6-phosphogluconate aldolase | Inactive | 20-Feb-2020 | ||
| CA-3170510-A1 | Genetically engineered plants that express 6-phosphogluconate dehydratase and/or 2-keto-3-deoxy-6-phosphogluconate aldolase | Pending | 20-Feb-2020 | C12N9/88 |
Yield10 Bioscience Signals
Yield10 Bioscience Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Archer Daniels Midland | Corporation | Minority | ||
| Aspire Capital | PE/Buyout | Minority | ||
| Birchview Capital | Hedge Fund | Minority | ||
| Hong Kong Sino-Science Oil & Gas | PE/Buyout | Minority | ||
| Maniv Bioventures | Venture Capital | Minority |
Yield10 Bioscience ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Chemicals
Industry
Rank
Percentile
Specialty Chemicals
Subindustry
Rank
Percentile
Yield10 Bioscience FAQs
-
When was Yield10 Bioscience founded?
Yield10 Bioscience was founded in 1992.
-
Where is Yield10 Bioscience headquartered?
Yield10 Bioscience is headquartered in Woburn, MA.
-
What is the size of Yield10 Bioscience?
Yield10 Bioscience has 42 total employees.
-
What industry is Yield10 Bioscience in?
Yield10 Bioscience’s primary industry is Other Agriculture.
-
Is Yield10 Bioscience a private or public company?
Yield10 Bioscience is a Private company.
-
What is the current valuation of Yield10 Bioscience?
The current valuation of Yield10 Bioscience is .
-
What is Yield10 Bioscience’s current revenue?
The current revenue for Yield10 Bioscience is .
-
How much funding has Yield10 Bioscience raised over time?
Yield10 Bioscience has raised $193M.
-
Who are Yield10 Bioscience’s investors?
Archer Daniels Midland, Aspire Capital, Birchview Capital, Hong Kong Sino-Science Oil & Gas, and Maniv Bioventures are 5 of 8 investors who have invested in Yield10 Bioscience.
-
Who are Yield10 Bioscience’s competitors?
Amyris (Biotechnology), Edeniq, Ecovia Bio, Cibus (Agriculture), and Viaspace are competitors of Yield10 Bioscience.
-
When was Yield10 Bioscience acquired?
Yield10 Bioscience was acquired on 01-Jan-2025.
-
Who acquired Yield10 Bioscience?
Yield10 Bioscience was acquired by Nuseed Global.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process